Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2006 Feb;27(1):1-10.

PMID:
16511362
2.
3.

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder.

Jensen P.

J Atten Disord. 2002;6 Suppl 1:S45-56. Review.

PMID:
12685518
4.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

5.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
6.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
7.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
8.

Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.

Cornforth C, Sonuga-Barke E, Coghill D.

Curr Pharm Des. 2010;16(22):2424-33. Review.

PMID:
20513225
9.

Stimulant drugs.

Santosh PJ, Taylor E.

Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I27-43. Review.

PMID:
11140778
10.

Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.

Poulton A.

Expert Rev Neurother. 2006 Apr;6(4):551-61. Review.

PMID:
16623654
11.

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.

Kociancic T, Reed MD, Findling RL.

Expert Opin Drug Saf. 2004 Mar;3(2):93-100. Review.

PMID:
15006715
12.

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.

Brams M, Moon E, Pucci M, López FA.

Curr Med Res Opin. 2010 Aug;26(8):1809-25. doi: 10.1185/03007995.2010.488553. Review.

PMID:
20491612
13.
14.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
15.

[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].

Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.

Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Review. Polish.

PMID:
19697788
16.

Attention-deficit hyperactivity disorder.

Calis KA, Grothe DR, Elia J.

Clin Pharm. 1990 Aug;9(8):632-42. Review. Erratum in: Clin Pharm 1991 Apr;10(4):261.

PMID:
1974836
17.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
18.

Forty years of methylphenidate treatment in Attention-Deficit/ Hyperactivity Disorder.

Conners CK.

J Atten Disord. 2002;6 Suppl 1:S17-30. Review.

PMID:
12685516
19.

[The role of zinc in the treatment of hyperactivity disorder in children].

Dodig-Curković K, Dovhanj J, Curković M, Dodig-Radić J, Degmecić D.

Acta Med Croatica. 2009 Oct;63(4):307-13. Review. Croatian.

PMID:
20034331
20.

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

Merkel RL Jr, Kuchibhatla A.

Expert Opin Drug Saf. 2009 Nov;8(6):655-68. doi: 10.1517/14740330903279956. Review.

PMID:
19785509

Supplemental Content

Support Center